| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |